Siirry sisältöön
Optomed
  • About us
    • Column1
    • Optomed’s story
    • Research and Development
    • IPR
    • Corporate Responsibility
    • News and events
    • Careers
    • Management
  • Products & Solutions
    • Column1
    • HANDHELD CAMERAS
    • Optomed Aurora IQ
    • Smartscope PRO
    • VET
    • Optomed E-Safe
    • DESKTOP CAMERAS
    • Optomed Polaris
    • Optomed Halo
    • Column2
    • NEUROLOGY
    • SOLUTIONS
    • Ophthalmology
    • Avenue SaaS
    • Avenue AI
    • Avenue Eye Screen
    • Avenue Telemedicine
    • Avenue Archive
    • Avenue Sync
    • Avenue Flow
    • Hidden item
    • Cancer Screening
    • Avenue Cancer Screen
    • Radiology
    • Optomed Radiology Information System (RIS)
    • Sectra PACS
    • Optomed Service Portal
    • Cephalometry
    • Pathology
    • Sectra PACS Pathology
  • Customers
    • Column1
    • References
    • Clinical studies
    • Scientific Advisory Board
  • Investors
    • Column1
    • OPTOMED AS AN INVESTMENT
    • Key figures
    • Business model
    • Markets
    • Strategy
    • Mission and values
    • Future outlook
    • Financial targets and dividend policy
    • Corporate Responsibility
    • INVESTOR RELATIONS
    • Column2
    • RELEASES AND PUBLICATIONS
    • Annual reports
    • Financial reports and presentations
    • Interviews
    • ANALYSTS
    • Column3
    • SHARES AND SHAREHOLDERS
    • Management transactions
    • Shareholders
    • Share monitor
    • Flagging notifications
    • Option Programs
    • Authorizations
    • IR CALENDAR
    • Investor events
    • Column4
    • CORPORATE GOVERNANCE
    • General Meeting
    • Previous General Meetings
    • Statements and Reports
    • Articles of association
    • Board of Directors
    • Committees
    • Shareholders’ Nomination Board
    • CEO and Leadership Team
    • Remuneration
    • Risk management
    • Insider management
    • External Auditor
    • Disclosure policy
    • Related party transactions
    • Whistleblowing instructions
    • IPO 2019
  • Contact
    • Column1
    • Where to buy
    • Support
    • Media
  • About us
    • Column1
    • Optomed’s story
    • Research and Development
    • IPR
    • Corporate Responsibility
    • News and events
    • Careers
    • Management
  • Products & Solutions
    • Column1
    • HANDHELD CAMERAS
    • Optomed Aurora IQ
    • Smartscope PRO
    • VET
    • Optomed E-Safe
    • DESKTOP CAMERAS
    • Optomed Polaris
    • Optomed Halo
    • NEUROLOGY
    • SOLUTIONS
    • Ophthalmology
    • Avenue SaaS
    • Avenue AI
    • Avenue Eye Screen
    • Avenue Telemedicine
    • Avenue Archive
    • Avenue Sync
    • Avenue Flow
    • Hidden item
    • Cancer Screening
    • Avenue Cancer Screen
    • Radiology
    • Optomed Radiology Information System (RIS)
    • Sectra PACS
    • Optomed Service Portal
    • Cephalometry
    • Pathology
    • Sectra PACS Pathology
  • Customers
    • Column1
    • References
    • Clinical studies
    • Scientific Advisory Board
  • Investors
    • Column1
    • OPTOMED AS AN INVESTMENT
    • Key figures
    • Business model
    • Markets
    • Strategy
    • Mission and values
    • Future outlook
    • Financial targets and dividend policy
    • Corporate Responsibility
    • INVESTOR RELATIONS
    • Column2
    • RELEASES AND PUBLICATIONS
    • Annual reports
    • Financial reports and presentations
    • Interviews
    • ANALYSTS
    • Column3
    • SHARES AND SHAREHOLDERS
    • Management transactions
    • Shareholders
    • Share monitor
    • Flagging notifications
    • Option Programs
    • Authorizations
    • IR CALENDAR
    • Investor events
    • Column4
    • CORPORATE GOVERNANCE
    • General Meeting
    • Previous General Meetings
    • Statements and Reports
    • Articles of association
    • Board of Directors
    • Committees
    • Shareholders’ Nomination Board
    • CEO and Leadership Team
    • Remuneration
    • Risk management
    • Insider management
    • External Auditor
    • Disclosure policy
    • Related party transactions
    • Whistleblowing instructions
    • IPO 2019
  • Contact
    • Column1
    • Where to buy
    • Support
    • Media
Optomed | Investors

Welcome to our investor pages

Medical technology company Optomed is leading producer of handheld fundus cameras globally.

Current highlights

Half-year Financial Report, January - June 2023 Results presentation, January – June 2023 Annual Report 2022 Optomed as an investment

Key figures

Net sales 14,7 EUR, million
Gross margin 68.7  %
EBITDA -2,0 EUR, million
Equity ratio 65.0%

Share Price
Nasdaq Helsinki Stock Exchange

Optomed’s Half-year report, January – June 2023

Read more

Latest releases

Read more

Investor events

Nov 3 - Nov 3, 2023

Interim Report for 1 January – 30 September 2023

Feb 15 - Feb 15, 2024

Financial Statement Bulletin for 1 January – 31 December 2023

May 7 - May 7, 2024

Interim Report for 1 January – 31 March 2024

Aug 8 - Aug 8, 2024

Half-Year Financial Report for 1 January – 30 June 2024

Nov 7 - Nov 7, 2024

Interim Report for 1 January – 30 September 2024

Aug 4 - Aug 4, 2023

Half-Year Financial Report for 1 January – 30 June 2023

Read more

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

Read more

Business

Complete solutions for screening – in any location.

Read more

Strategy

The company has a long-term growth strategy comprising three key paths.

Read more

Key Figures

Read the latest key figures.

Read more
Support Contact Privacy statement
  • FacebookFacebook
  • TwitterTwitter
  • YouTubeYouTube
  • LinkedInLinkedIn

Optomed is a Valued Supplier on the IAPB Standard List

 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

Our camera products have medical approvals in all key markets, including CE (Europe) and FDA (USA), and CFDA (China).

We use cookies for analytics to improve your experience with us. To find out more, have a look at our Privacy Policy and Cookie Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked. Accept AllCustomize
Privacy & Cookies Policy

Privacy Overview

We use cookies for analytics to improve your experience with us. To find out more, have a look at our Privacy Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Save & Accept